Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Research

Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study

Vishnupriya Ramakrishnan, Suganeshwari Soundarapandian.

Background: Angiotensin-converting enzyme (ACE) inhibitors are commonly used in clinical practice to treat hypertension. Hyperkalemia develops in approximately 10% of outpatients within a year of prescription of these drugs.

Aim and Objective: The aim of this study was to identify the prevalence of hyperkalemia among outpatients who are taking ACE inhibitors for hypertension for more than 6 months.

Materials and Methods: This was a cross-sectional study conducted in the Hypertension Clinic, Tirunelveli Medical College. Around 152 hypertensive patients taking ACE inhibitors for more than 6 months were enrolled in the study. Blood samples were obtained, and their serum potassium levels were measured.

Results: Among 152 patients, there were 88 male patients (57.9%) and 64 female patients (42.1%). Ten patients (35.71%) out of 18 patients who were on monotherapy presented with hyperkalemia and 20 patients (16.12%) out of 104 patients who were on combination therapy had hyperkalemia. A higher number of patients with hyperkalemia falls in the age group of 46–60 years of age. Out of 152 patients who took enalapril, 30 patients (19.73%) were found to have hyperkalemia. Of them, 20 patients (13.15%) had mild hyperkalemia, and ten patients (6.57%) had moderate hyperkalemia. There were no cases of severe hyperkalemia.

Conclusion: Hence, it is of considerable importance for physicians to identify patients at risk by regular monitoring and to implement measures to lessen the likelihood of the development of hyperkalemia.

Key words: Hyperkalemia; Hypertension; Angiotensin-converting enzyme inhibitors

Similar Articles

Synthetic Strategies for FRET-Enabled Carbohydrate Active Enzyme Probes.
Singh M, Watkinson M, Scanlan EM, Miller GJ
Methods in molecular biology (Clifton, N.J.). 2022; 2370(): 237-264

Biochemical and Biological Assays of Mycolactone-Mediated Inhibition of Sec61.
O'Keefe S, High S, Demangel C
Methods in molecular biology (Clifton, N.J.). 2022; 2387(): 163-181

Hydrogel Formation with Enzyme-Responsive Cyclic Peptides.
Carlini AS, Cassidy MF, Gianneschi NC
Methods in molecular biology (Clifton, N.J.). 2022; 2371(): 427-448

Binding Characterization of Cyclic Peptide Ligands to Target Proteins and Chemical Epitopes Using ELISA and Fluorescence Polarization Assays.
Borges A, Onasenko I, Nag A
Methods in molecular biology (Clifton, N.J.). 2022; 2371(): 335-354

Cryo-self-assembled silk fibroin sponge as a biodegradable platform for enzyme-responsive delivery of exosomes.
Sun M, Li Q, Yu H, Cheng J, Wu N, Shi W, Zhao F, Shao Z, Meng Q, Chen H, Hu X, Ao Y
Bioactive materials. 2022; 8(): 505-514

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.

ScopeMed Web Sites